Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CD69 | Q07108 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20516489 | 1.00 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL14520991 | 1.00 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL6552473 | 1.00 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL13575286 | 1.00 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL15504324 | 1.00 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL57603 | 1.00 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBESR1 | |
| N-Acetylglucosamine SCHEMBL28342076 | 0.97 | MAPK1 (0.95) | MAPK1NOD2ALDH1A1THRBESR1 | |
| Sulfuric Acid SCHEMBL3262877 | 0.95 | MAPK1 (0.91) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL31124790 | 0.89 | MAPK1 (0.80) | MAPK1NOD2ALDH1A1THRBESR1 | |
| SCHEMBL23247948 | 0.89 | MAPK1 (0.80) | MAPK1NOD2ALDH1A1THRBESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4001 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060658-A | Engineering bacterium for synthesizing N-acetylglucosamine, construction method and application thereof | 金华利家园生物工程有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260085293-A1 | SOLUTION AND METHOD FOR TRANSPORTING OR STORING BODY FLUID SAMPLE | PROVIGATE INC (JP) | 2026-03-26 | — | — | US | claimed |
| EP-4692792-A1 | SOLUTION AND METHOD FOR TRANSPORTING OR STORING BODY FLUID SAMPLE | Provigate Inc. (JP) | 2026-02-11 | — | — | EP | claimed |
| WO-2025245227-A1 | BACTERIAL CELL WALL COMPONENTS AS PROBES FOR A LABEL-FREE BINDING ASSAY AND THE USE THEREOF | ACADEMIA SINICA (TW) | 2025-11-27 | — | — | WO | claimed |
| US-20250295729-A1 | NOVEL THERAPEUTIC METHODS OF USING PEPTIDOGLYCAN MUROPEPTIDES TO PROMOTE ATP SYNTHASE ACTIVITY AND MITOCHONDRIAL HOMEOSTASIS AND DEVELOPMENT | UNIV COLORADO REGENTS (US) | 2025-09-25 | — | — | US | claimed |
| EP-4588489-A1 | LINKER FOR ANTIBODY-DRUG CONJUGATE AND USE THEREOF | Shanghai Junshi Biosciences Co., Ltd. (CN) | 2025-07-23 | — | — | EP | claimed |
| CN-119894537-A | Linker for antibody drug conjugates and uses thereof | 上海君实生物医药科技股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119365778-A | Solutions and methods for transporting or preserving body fluid samples | 株式会社普欧威盖特 | 2025-01-24 | — | — | CN | claimed |
| WO-2024204342-A1 | SOLUTION AND METHOD FOR TRANSPORTING OR STORING BODY FLUID SAMPLE | 株式会社PROVIGATE | 2024-10-03 | — | — | WO | claimed |
| US-20240294958-A1 | EXTRACELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS | INBIOSE NV (BE) | 2024-09-05 | — | — | US | claimed |
| WO-1997023608-A1 | COMPOSITIONS AND METHODS FOR TARGETING GENE DELIVERY VEHICLES USING COVALENTLY BOUND TARGETING ELEMENTS | CHIRON CORPORATION (US) | 1997-07-03 | — | — | WO | claimed |
| EP-0667145-B1 | Stabilized cosmetic or dermatologic composition containing several precursors of a same active agent | OREAL (FR) | 1996-09-25 | — | — | EP | claimed |
| WO-1990013030-A1 | METHOD OF DETERMINING THE GRAM SIGN OF BACTERIA | THE UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) | 1990-11-01 | — | — | WO | claimed |
| WO-1990002336-A1 | IMMUNOASSAY FOR DETERMINING A CHLAMYDIAL ANTIGEN COMPRISING PRETREATMENT OF THE SAMPLE WITH A CHELATING AGENT | CELLTECH DIAGNOSTICS LIMITED (GB) | 1990-03-08 | — | — | WO | claimed |
| EP-0145242-B1 | ASSAY PRETREATMENT METHOD, COMPOSITON THEREFOR AND AGGLUTINATION ASSAY KIT CONTAINING IT | SYNTEX (U.S.A.) INC. (US) | 1988-03-30 | — | — | EP | claimed |
| US-4634663-A | ENZYMATIC OXIDATION | NODA INSTITUTE FOR SCIENTIFIC RESEARCH (JP) | 1987-01-06 | — | — | US | claimed |
| EP-0100734-B1 | PROCESS FOR THE SEPARATION OR PURIFICATION OF A SLEEP PROMOTING FACTOR FROM A BIOLOGICAL SOURCE BY IMMUNOLOGICAL REACTION OF THE ANTIGEN-ANTIBODY KIND | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1986-12-17 | — | — | EP | claimed |
| US-4617264-A | Pretreatment method and composition | SYNTEX (U.S.A.) INC. (US) | 1986-10-14 | — | — | US | claimed |
| EP-0145242-A1 | Assay pretreatment method, compositon therefor and agglutination assay kit containing it | SYNTEX (U.S.A.) INC. (US) | 1985-06-19 | — | — | EP | claimed |
| US-4001395-A | HYDROSOLUBLE EXTRACTS OF MYCOBACTERIA | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-01-04 | — | — | US | claimed |